Takeda Pharmaceutical Co Stock Market Value
| TAK Stock | USD 13.33 0.04 0.30% |
| Symbol | Takeda |
Takeda Pharmaceutical Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Takeda Pharmaceutical. If investors know Takeda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Takeda Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.049 | Dividend Share 192 | Earnings Share 0.59 | Revenue Per Share 1.4 K | Quarterly Revenue Growth 0.127 |
The market value of Takeda Pharmaceutical is measured differently than its book value, which is the value of Takeda that is recorded on the company's balance sheet. Investors also form their own opinion of Takeda Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Takeda Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Takeda Pharmaceutical's market value can be influenced by many factors that don't directly affect Takeda Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Takeda Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Takeda Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Takeda Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Takeda Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Takeda Pharmaceutical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Takeda Pharmaceutical.
| 10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in Takeda Pharmaceutical on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Takeda Pharmaceutical Co or generate 0.0% return on investment in Takeda Pharmaceutical over 30 days. Takeda Pharmaceutical is related to or competes with Viatris, Elanco Animal, Zoetis, Emergent Biosolutions, Prestige Brand, Amphastar, and Pacira BioSciences,. Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of... More
Takeda Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Takeda Pharmaceutical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Takeda Pharmaceutical Co upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.27) | |||
| Maximum Drawdown | 4.86 | |||
| Value At Risk | (1.91) | |||
| Potential Upside | 1.28 |
Takeda Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Takeda Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Takeda Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Takeda Pharmaceutical historical prices to predict the future Takeda Pharmaceutical's volatility.| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (0.15) | |||
| Total Risk Alpha | (0.26) | |||
| Treynor Ratio | (6.44) |
Takeda Pharmaceutical Backtested Returns
Takeda Pharmaceutical owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.14, which indicates the firm had a -0.14% return per unit of risk over the last 3 months. Takeda Pharmaceutical Co exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Takeda Pharmaceutical's Variance of 0.8222, risk adjusted performance of (0.11), and Coefficient Of Variation of (678.10) to confirm the risk estimate we provide. The entity has a beta of 0.0223, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Takeda Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Takeda Pharmaceutical is expected to be smaller as well. At this point, Takeda Pharmaceutical has a negative expected return of -0.13%. Please make sure to validate Takeda Pharmaceutical's potential upside, as well as the relationship between the daily balance of power and market facilitation index , to decide if Takeda Pharmaceutical performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.3 |
Weak reverse predictability
Takeda Pharmaceutical Co has weak reverse predictability. Overlapping area represents the amount of predictability between Takeda Pharmaceutical time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Takeda Pharmaceutical price movement. The serial correlation of -0.3 indicates that nearly 30.0% of current Takeda Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.3 | |
| Spearman Rank Test | -0.22 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Takeda Pharmaceutical lagged returns against current returns
Autocorrelation, which is Takeda Pharmaceutical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Takeda Pharmaceutical's stock expected returns. We can calculate the autocorrelation of Takeda Pharmaceutical returns to help us make a trade decision. For example, suppose you find that Takeda Pharmaceutical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Takeda Pharmaceutical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Takeda Pharmaceutical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Takeda Pharmaceutical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Takeda Pharmaceutical stock over time.
Current vs Lagged Prices |
| Timeline |
Takeda Pharmaceutical Lagged Returns
When evaluating Takeda Pharmaceutical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Takeda Pharmaceutical stock have on its future price. Takeda Pharmaceutical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Takeda Pharmaceutical autocorrelation shows the relationship between Takeda Pharmaceutical stock current value and its past values and can show if there is a momentum factor associated with investing in Takeda Pharmaceutical Co.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Takeda Pharmaceutical Correlation, Takeda Pharmaceutical Volatility and Takeda Pharmaceutical Alpha and Beta module to complement your research on Takeda Pharmaceutical. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Takeda Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.